Please login to the form below

Not currently logged in
Email:
Password:

RWE

This page shows the latest RWE news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim, Lifebit to use AI to detect infectious disease outbreaks

Boehringer Ingelheim, Lifebit to use AI to detect infectious disease outbreaks

Lifebit’s AI-enabled real-world evidence (RWE) analysis system – REAL – uses advanced analytic capabilities to automatically let users known of any relevant outbreaks. ... At Lifebit, we thrive on connecting both locked-up sensitive biomedical data

Latest news

More from news
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest Intelligence

  • Understanding the ‘real world’ starts and ends with the patient Understanding the ‘real world’ starts and ends with the patient

    For that, we need real-world evidence (RWE) generated in real-world studies. ... This makes a network of robust, transparent and reliable RWE, such as PHederation, a vital tool.

  • Encouraging patient participation in real-world studies Encouraging patient participation in real-world studies

    ICON:Randomised clinical trials (RCTs) aren’t about to be replaced by studies based on real-world evidence (RWE), although RWE certainly is a disrupter that’s being used in many

  • Real-world studies Real-world studies

    It’s within this context that a comprehensive RWE strategy should be developed to support the overall commercial objectives of a product. ... How can life sciences companies stay ahead of the curve in collecting and providing RWE that their

  • The evolution of real-world studies The evolution of real-world studies

    Ten of the 19 RWE- related requests involved the use of historical controls. ... UK strength. The level of trust placed in RWE depends largely on the source of the data.

  • 25 Women Leaders in UK Healthcare (part 2) 25 Women Leaders in UK Healthcare (part 2)

    RWE) to derive new insights for the ultimate benefit of patients. ... Dr Harietta Eleftherochorinou, IQVIA’s senior principal RWE AI and machine learning (ML), is a leading light in applying the techniques to pharma’s commercial challenges, including

More from intelligence
Approximately 0 fully matching, plus 23 partially matching documents found.

Latest from PMHub

  • Cegedim Health Data UK

    We are your trusted partner for Real World Data (RWD), Real World Evidence (RWE), Advanced Analytics and Health Data Services.

  • Blockchain for Tracking and Validating Medical Cannabis

    Robert Galarza, CEO of TruTrace Technologies, Inc., dives into the use of blockchain technology for verifying medical cannabis products and protecting intellectual property. He also shares his leadership tips and predictions for the future of the

  • Impact of COVID-19 on the Biopsychosocial Model of Health

    Dr. Tarry Ahuja, Manager of Program Development in Pharmaceutical Reviews and Senior RWE Advisor at CADTH, explores the impact of COVID-19 on the biopsychosocial model of health, key opportunities and ... barriers to RWE throughout the drug lifecycle,

  • Real-world evidence: breaking boundaries in rare disease

    Sonal Bhatia, Vice President, Medical Affairs Rare Disease at Pfizer,   explains that real‑world evidence (RWE) provides a useful way of overcoming some of these challenges. ... As a result, there are several barriers life science companies need to

  • Effects of the Pandemic on Evidence Generation & Scientific Exchange

    Farah Husein, Director, Evidence Generation, Canadian Centre of Excellence, at  Takeda, discusses all things evidence generation, including the impact of the COVID-19 pandemic on HEOR, RWE, epidemiology, and PRO studies

More from PMHub
Approximately 3 fully matching, plus 10 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...